A fragment analog, [D-Arg30]prothymosin α fragment 1-30, containing D-arginine in place of arginine residue at position 30 was synthesized by the liquid phase procedure and studied for immunological effect on the impaired blastogenic response of T-lymphocytes isolated from uremic patients after treatment of human serum. Deacetyl-thymosin α1, a synthetic octaeicosapeptide corresponding to deacetyl-prothymosin α fragment 1-28, has restoration ability for the impaired blastogenic response of T-lymphocytes of uremic patients but is susceptible to proteolytic digestion. On the other hand, the fragment analog, [D-Arg30]prothymosin α fragment 1-30 retained activity and was shown to exhibit a high degree of stability when incubated in human serum. These results indicate that N-terminal acetylation and the introduction of D-residue into the C-terminal residue of prothymosin α fragment 1-30 increase resistance to proteolytic degradation by exopeptidases.
通过液相法合成了一种片段类似物[D-Arg30]胸腺肽α片段1-30,该片段含有
D-精氨酸,取代了第30位的精
氨酸残基。脱乙酰胸腺肽α1是一种与脱乙酰胸腺肽α片段1-28相对应的合成八代肽,它对尿毒症患者T淋巴细胞受损的鼓泡生成反应具有恢复能力,但易被
蛋白酶消化。另一方面,片段类似物[D-Arg30]原胸腺肽α片段 1-30 保留了活性,并且在人血清中培养时表现出高度稳定性。这些结果表明,原胸腺肽α片段1-30的N端乙酰化和在C端残基中引入D-残基可增强对外肽酶蛋白分解的抵抗力。